Clinical Trials Network - Network Organization

Skip Navigation

NIDA NEWS

The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse

Search the NIDA website

Oregon/Hawaii Node

The Oregon-Hawaii Node is a bi-directional clinical trial partnership of two research and training organizations -- Oregon Health & Science University with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii -- and eight multi-modality drug treatment programs located in urban and rural communities in Oregon, Hawaii, and Washington. These programs serve a growing number of Latino, Native American, Hawaiian, Russian, Asian, and female clients. Services are provided across the treatment continuum.

Regional Research and Training Center

Oregon Health Sciences University
3181 S. W. Sam Jackson Park Road, CB 669
Portland, OR 97201-3098

Principal Investigator

Dennis McCarty, Ph.D.
Professor
Department of Public Health and Preventive Medicine
Oregon Health & Science University
3181 S.W. Sam Jackson Park Rd.
CB 669
Portland, OR 97239
503-494-1177 (Voice)
mccartyd@ohsu.edu

Community Treatment Programs

ADAPT, Inc.
Roseburg, OR

BestCare Treatment Services
Redmond, OR

Big Island Substance Abuse Council
Kaneohe, HI

ChangePoint, Inc.
Portland, OR

Choctaw Nation of Oklahoma
P.0. Drawer 1210, Durant, OK

CODA, Inc.
Portland, OR

Kaiser Permanente, Department of Addiction Medicine
Portland, OR

Native American Rehabilitation Association of the Northwest, Inc.
Portland, OR

New Directions Northwest
Baker City, OR

Oregon Treatment Network
Baker City, OR

Willamette Family Treatment Services
Eugene, OR

Oregon/Hawaii Protocol Involvement
PROTOCOL0002	Buprenorphine/Naloxone for Opiate Detoxification - OUTpatient
PROTOCOL0003	Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0005	Motivational Interviewing (MI)
PROTOCOL0008	A Baseline for Investigating Diffusion of Innovation
PROTOCOL0012	Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0017	HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings
PROTOCOL0020	Job-Seekers Training for Patients with Drug Dependence
PROTOCOL0021	Motivational Enhancement Treatment (MET)To Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
PROTOCOL0027	Starting Treatment with Agonist Replacement Therapies - START
PROTOCOL0029	A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
PROTOCOL0030	Prescription Opioid Addiction Treatment Study (POATS)
PROTOCOL0031	Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
PROTOCOL0032	HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, July 14, 2008.